Literature DB >> 12011462

Mailborne transmission of anthrax: Modeling and implications.

Glenn F Webb1, Martin J Blaser.   

Abstract

A mathematical model is developed to analyze the transmission of inhalational anthrax through the postal system by cross-contamination of mail. The model consists of state vectors describing the numbers of cross-contaminated letters generated, the numbers of anthrax spores on these letters, the numbers of resulting infections in recipients, and matrices of transition probabilities acting on these vectors. The model simulates the recent outbreak in the United States, and provides a general framework to investigate the potential impact of possible future outbreaks.

Entities:  

Mesh:

Year:  2002        PMID: 12011462      PMCID: PMC124522          DOI: 10.1073/pnas.102691499

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

Review 1.  Anthrax.

Authors:  T C Dixon; M Meselson; J Guillemin; P C Hanna
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

2.  Discussion.

Authors:  H N Glassman
Journal:  Bacteriol Rev       Date:  1966-09

3.  Differences in susceptibility of inbred mice to Bacillus anthracis.

Authors:  S L Welkos; T J Keener; P H Gibbs
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

4.  Value of field data for extrapolation in anthrax.

Authors:  R E Lincoln; J S Walker; F Klein; A J Rosenwald; W I Jones
Journal:  Fed Proc       Date:  1967-09

5.  The Sverdlovsk anthrax outbreak of 1979.

Authors:  M Meselson; J Guillemin; M Hugh-Jones; A Langmuir; I Popova; A Shelokov; O Yampolskaya
Journal:  Science       Date:  1994-11-18       Impact factor: 47.728

6.  Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay.

Authors:  L H Harrison; J W Ezzell; T G Abshire; S Kidd; A F Kaufmann
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

7.  Contagion on the Internet.

Authors:  Trudy M Wassenaar; Martin J Blaser
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

Review 8.  Information on which to base assessments of risk from environments contaminated with anthrax spores.

Authors:  A Watson; D Keir
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

Review 9.  A review of human salmonellosis: I. Infective dose.

Authors:  M J Blaser; L S Newman
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

10.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Authors:  J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  15 in total

1.  Using temporal context to improve biosurveillance.

Authors:  Ben Y Reis; Marcello Pagano; Kenneth D Mandl
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

2.  Operational effectiveness of suicide-bomber-detector schemes: a best-case analysis.

Authors:  Edward H Kaplan; Moshe Kress
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-05       Impact factor: 11.205

3.  Sverdlovsk revisited: modeling human inhalation anthrax.

Authors:  Dean A Wilkening
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-05       Impact factor: 11.205

4.  Modeling the host response to inhalation anthrax.

Authors:  Judy Day; Avner Friedman; Larry S Schlesinger
Journal:  J Theor Biol       Date:  2011-02-03       Impact factor: 2.691

5.  Multigeneration cross contamination of mail with Bacillus species spores by tumbling.

Authors:  Jason Edmonds; Paul Clark; Leslie Williams; H D Alan Lindquist; Kenneth Martinez; Warren Gardner; Sean Shadomy; Jennifer Hornsby-Myers
Journal:  Appl Environ Microbiol       Date:  2010-05-28       Impact factor: 4.792

6.  Ecological theory to enhance infectious disease control and public health policy.

Authors:  Katherine F Smith; Andrew P Dobson; F Ellis McKenzie; Leslie A Real; David L Smith; Mark L Wilson
Journal:  Front Ecol Environ       Date:  2005-02-01       Impact factor: 11.123

7.  Inhalation anthrax: dose response and risk analysis.

Authors:  Margaret E Coleman; Brandolyn Thran; Stephen S Morse; Martin Hugh-Jones; Stacey Massulik
Journal:  Biosecur Bioterror       Date:  2008-06

8.  Mechanistic modeling of emergency events: assessing the impact of hypothetical releases of anthrax.

Authors:  S S Isukapalli; P J Lioy; P G Georgopoulos
Journal:  Risk Anal       Date:  2008-06       Impact factor: 4.000

9.  Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings.

Authors:  Daniel B Jernigan; Pratima L Raghunathan; Beth P Bell; Ross Brechner; Eddy A Bresnitz; Jay C Butler; Marty Cetron; Mitch Cohen; Timothy Doyle; Marc Fischer; Carolyn Greene; Kevin S Griffith; Jeannette Guarner; James L Hadler; James A Hayslett; Richard Meyer; Lyle R Petersen; Michael Phillips; Robert Pinner; Tanja Popovic; Conrad P Quinn; Jennita Reefhuis; Dori Reissman; Nancy Rosenstein; Anne Schuchat; Wun-Ju Shieh; Larry Siegal; David L Swerdlow; Fred C Tenover; Marc Traeger; John W Ward; Isaac Weisfuse; Steven Wiersma; Kevin Yeskey; Sherif Zaki; David A Ashford; Bradley A Perkins; Steve Ostroff; James Hughes; David Fleming; Jeffrey P Koplan; Julie L Gerberding
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

10.  Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001.

Authors:  Kevin S Griffith; Paul Mead; Gregory L Armstrong; John Painter; Katherine A Kelley; Alex R Hoffmaster; Donald Mayo; Diane Barden; Renee Ridzon; Umesh Parashar; Eyasu Habtu Teshale; Jennifer Williams; Stephanie Noviello; Joseph F Perz; Eric E Mast; David L Swerdlow; James L Hadler
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.